# Bladder Cancer Advocacy Network: Observational study in NMIBC, MIBC (1400 participants)

**Score:** 65/100

| Field | Value |
|---|---|
| Sponsor | Bladder Cancer Advocacy Network |
| Sponsor type | Academic and hospital |
| Study | Outcomes for IR and High Risk (HR) Non-muscle Invasive Bladder Cancer (NMIBC) and ctDNA-based Biomarkers for Response and Recurrence in Muscle Invasive Bladder Cancer (MIBC) |
| NCT ID | NCT07893509 |
| Phase | Observational |
| Status | not yet recruiting |
| Conditions | NMIBC; MIBC; Muscle Invasive Bladder Cancer (MIBC); Non Muscle Invasive Bladder Cancer |
| Intervention types | other |
| Target enrollment | 1400 |
| Site countries | United States |
| Posted | 2026-10-26 |
| Planned start | 2027-03 |
| Event | Newly registered study |
| Event date | 2026-10-26 |

## Why this score
- Posted in the last two weeks.
- 1400 participants planned.
- Not yet recruiting: vendors still being chosen.

Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2 (https://clinicaltrials.gov/study/NCT07893509). Last refreshed: 2026-11-04T06:04:38.232Z.
From public ClinicalTrials.gov registrations. Sponsor and study level only: we never list investigators, contacts or participants. A registration describes a planned study and can change. Status changes are read from each study's current status, actual dates and latest posted update, not a full change history, so an update can be a correction rather than a new change. Verify on ClinicalTrials.gov.